These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36535910)

  • 1. Economic Evaluation of Dialectical Behavioral Therapy Versus Cognitive Behavioral Therapy for Suicide Prevention.
    Acolin J
    J Ment Health Policy Econ; 2022 Dec; 25(4):123-131. PubMed ID: 36535910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US.
    Ross EL; Zuromski KL; Reis BY; Nock MK; Kessler RC; Smoller JW
    JAMA Psychiatry; 2021 Jun; 78(6):642-650. PubMed ID: 33729432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial interventions for self-harm in adults.
    Witt KG; Hetrick SE; Rajaram G; Hazell P; Taylor Salisbury TL; Townsend E; Hawton K
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013668. PubMed ID: 33884617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H; Beeber LS; Schwartz TA; Lewis G
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model.
    Ross EL; Vijan S; Miller EM; Valenstein M; Zivin K
    Ann Intern Med; 2019 Dec; 171(11):785-795. PubMed ID: 31658472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review.
    Li M; Bai F; Yao L; Qin Y; Chen K; Xin T; Ma X; Ma Y; Zhou Y; Dai H; Li R; Li X; Yang K
    Value Health; 2022 Jun; 25(6):1030-1041. PubMed ID: 35422392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost Effectiveness of Cognitive Behavioral Therapy for the Treatment of Subjective Tinnitus in Australia.
    Patel N; Malicka AN; McGinnity S; Anderson RB; Paolini AG; Crosland P
    Ear Hear; 2022; 43(2):507-518. PubMed ID: 34456302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Evaluation of Brief Cognitive Behavioral Therapy vs Treatment as Usual for Suicidal US Army Soldiers.
    Bernecker SL; Zuromski KL; Curry JC; Kim JJ; Gutierrez PM; Joiner TE; Kessler RC; Nock MK; Rudd MD; Bryan CJ
    JAMA Psychiatry; 2020 Mar; 77(3):256-264. PubMed ID: 31774485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Cost Effectiveness of a Suicide Prevention Campaign Implemented in Ontario, Canada.
    Lebenbaum M; Cheng J; de Oliveira C; Kurdyak P; Zaheer J; Hancock-Howard R; Coyte PC
    Appl Health Econ Health Policy; 2020 Apr; 18(2):189-201. PubMed ID: 31535350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
    Luciano JV; D'Amico F; Cerdà-Lafont M; Peñarrubia-María MT; Knapp M; Cuesta-Vargas AI; Serrano-Blanco A; García-Campayo J
    Arthritis Res Ther; 2014 Oct; 16(5):451. PubMed ID: 25270426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?
    Albright RH; Joseph RM; Wukich DK; Armstrong DG; Fleischer AE
    Clin Orthop Relat Res; 2020 Dec; 478(12):2869-2888. PubMed ID: 32694315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of internet-delivered cognitive-behavioural therapy for adolescents with irritable bowel syndrome.
    Sampaio F; Bonnert M; Olén O; Hedman E; Lalouni M; Lenhard F; Ljótsson B; Ssegonja R; Serlachius E; Feldman I
    BMJ Open; 2019 Jan; 9(1):e023881. PubMed ID: 30679293
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.